ArticleJACS Au2025
Light-Sensitive Ion Channel Delivery System for Ion-Interference Tumor Therapy.
Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Dual pH- and Concentration-Dependent KJACS Au · 2026Article
- The Cross-Species Implantable ATP Battery Inspired by Photosynthesis for Application in Diseases.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial ion channels have shown great potential applications in tumor treatment by disrupting ion homeostasis across cancer cell membranes. Herein, we report a de novo-designed ion channel delivery system (ICDS) based on light-sensitive nanocapsules that can induce cell apoptosis via interfering with ion homeostasis of subcellular membranes of tumors. The nanocapsules were self-assembled by the host-guest complex of azobenzene-modified quinoline helix (an artificial proton channel) and α-cyclodextrin, which can easily enter tumor cells by an endocytic effect and release proton channels under ultraviolet (UV) light irradiation. The artificial proton channels further neutralize the acidic organelles (such as lysosomes), deplete the mitochondrial membrane potential, elevate reactive oxygen species (ROS) levels, and eventually induce the apoptosis of cancer cells. As far as we know, this is the first example of an ion-interference antitumor strategy by an ion channel delivery system that may offer novel therapeutic directions for artificial ion channels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.